COHERUS BIOSCIENCES
Coherus Biosciences is a biopharmaceutical company that engages in the development, manufacture, and commercialization of biologic therapeutics. The company develops biologic medicines primarily for the treatment of oncology and inflammatory diseases. It focuses on process science, analytical characterization, protein production, and clinical-regulatory development. Its pipeline includes Immunology, anti-tumor necrosis factor (Anti-TNF) biosimilar candidates; Ophthalmology biosimilar candidates; and Oncology Biosimilar candidates.
COHERUS BIOSCIENCES
Industry:
Biotechnology Health Care Manufacturing Medical Therapeutics
Founded:
2007-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.coherus.com
Total Employee:
251+
Status:
Active
Contact:
(650) 649-3530
Total Funding:
602.51 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Viragen
Viragen researches, develops, manufactures and commercializes therapeutic proteins for the treatment of cancers and viral diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-02-12 | InteKrin | InteKrin acquired by Coherus Biosciences | 5 M USD |
Investors List
Pharmakon Advisors
Pharmakon Advisors investment in Post-IPO Debt - Coherus Biosciences
Shanghai Junshi Biosciences
Shanghai Junshi Biosciences investment in Post-IPO Equity - Coherus Biosciences
Lord Abbett
Lord Abbett investment in Post-IPO Equity - Coherus Biosciences
HealthCare Royalty Partners
HealthCare Royalty Partners investment in Post-IPO Debt - Coherus Biosciences
Kohlberg Kravis Roberts
Kohlberg Kravis Roberts investment in Series C - Coherus Biosciences
KMG Capital Partners
KMG Capital Partners investment in Series C - Coherus Biosciences
Viva Capital Advisors
Viva Capital Advisors investment in Series C - Coherus Biosciences
Sofinnova Investments
Sofinnova Investments investment in Series C - Coherus Biosciences
Eight Roads Ventures
Eight Roads Ventures investment in Series C - Coherus Biosciences
Rock Springs Capital
Rock Springs Capital investment in Series C - Coherus Biosciences
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-15 | Coherus BioSciences Appoints Rosh Dias, MD, MRCP, Chief Medical Officer |
| 2021-12-17 | Coherus BioSciences Appoints Theresa LaVallee, Ph.D., Chief Development Officer |
Official Site Inspections
http://www.coherus.com Semrush global rank: 2.83 M Semrush visits lastest month: 5.73 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Coherus Biosciences"
Corporate Overview - Coherus BioSciences, Inc.
Coherus’ earlier-stage immuno-oncology pipeline includes CHS-1000, a proprietary ILT4 …See details»
Coherus Biosciences - Crunchbase Company Profile & Funding
Coherus Biosciences may be growing as evidenced by the reported growth in net revenue for …See details»
Coherus | Innovative Immunotherapies for Cancer | About
Every member of the Coherus team is dedicated, motivated, and passionate about improving patient care. Our colleagues are experts in immunology, analytical and process sciences, biologic process development, manufacturing …See details»
Coherus | Novel Immuno-Oncology Medicines | Our …
When I joined Coherus in June 2021 as the Director and head of QC stability, I was inspired by the company mission to bring lifesaving therapeutics to patients at reduced costs without compromising quality. ... We create long-term value …See details»
Coherus BioSciences - Org Chart, Teams, Culture & Jobs - The Org
Coherus BioSciences is the leading biologics platform company solely focused on delivering …See details»
Coherus BioSciences, Inc. | Overview
Dec 3, 2024 Coherus is developing an innovative immuno-oncology pipeline that will …See details»
Coherus BioSciences - Company Profile & Staff Directory
Coherus BioSciences is the leading biologics platform company solely focused on delivering …See details»
Coherus BioSciences - Overview, News & Similar companies
May 15, 2024 REDWOOD CITY, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Coherus …See details»
Coherus BioSciences - Golden
Coherus Biosciences is a biotechnology company in California that focuses on developing, …See details»
Coherus’s Competitors, Revenue, Number of Employees, Funding …
Coherus’s Profile, Revenue and Employees. Coherus is a California-based biopharmaceutical …See details»
Coherus Biosciences - Contacts, Employees, Board Members
Organization. Coherus Biosciences . Connect to CRM . Save . Summary. Financials. People. …See details»
Coherus BioSciences, Inc. - Drug pipelines, Patents, Clinical
Nov 1, 2024 Explore Coherus BioSciences, Inc. with its drug pipeline, therapeutic area, …See details»
Coherus BioSciences, Inc. | Coherus BioSciences Reports Third …
– Net revenue of $70.8 million in Q3 2024 driven by 30% increase in UDENYCA ® net …See details»
Immuno-Oncology Therapies | Contact - Coherus BioSciences
Coherus is committed to developing and commercializing next-generation immuno-oncology …See details»
How Does Coherus Biosciences Work? – CBM
Dec 19, 2024 Coherus Biosciences is a leading biotechnology company that operates in the …See details»
Dennis M. Lanfear - Coherus BioSciences
Denny Lanfear founded Coherus in 2010 and is President and Chief Executive Officer. Denny …See details»
Coherus BioSciences, Inc. | Coherus Announces Agreement to …
REDWOOD CITY, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. …See details»
Coherus to Report Third Quarter 2024 Financial Results on …
Oct 30, 2024 Starting at 5:00 p.m. ET on November 6, 2024, Coherus’ management team will …See details»
Patient Advocacy - Coherus BioSciences
What does next generation patient advocacy mean at Coherus? A corporate culture …See details»